Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

With the MiSeq™ i100 Series, Illumina continues to set the highest standards.Advancements in system design, sequencing chemistry, and data analysis deliverthe simplest, fastest benchtop sequencing and ...

The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...

AI-Powered systems and runway upgrades aim to significantly reduce flight disruptions from fog at Delhi's IGI airport.

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

Delhi Airport has significantly strengthened its winter fog preparedness by deploying AI-driven systems, advanced predictive analytics and fully CAT-III compliant runways to ensure safer and smoother ...

MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can ...

TARGETED treatments for prostate cancer were a central theme at the European Society for Medical Oncology (ESMO) Congress ...

ServerDomes is partnering with Global Green Generation, a global engineering and construction management organization ...

The bank’s ‘Today, Tomorrow, Forever’ framework helps families organise and navigate their wealth across three interconnected ...

Some younger patients with B-cell acute lymphoblastic leukemia may be able to avoid total body irradiation conditioning prior ...

In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after ...